478 related articles for article (PubMed ID: 28963934)
1. Factors associated with occurrence and outcome of super-refractory status epilepticus.
Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
3. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
[TBL] [Abstract][Full Text] [Related]
4. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
[TBL] [Abstract][Full Text] [Related]
5. Super-refractory status epilepticus in West China.
Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D
Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275
[TBL] [Abstract][Full Text] [Related]
6. The etiology and prognosis of super-refractory convulsive status epilepticus in children.
Lu WY; Weng WC; Wong LC; Lee WT
Epilepsy Behav; 2018 Sep; 86():66-71. PubMed ID: 30006260
[TBL] [Abstract][Full Text] [Related]
7. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.
Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F
Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418
[TBL] [Abstract][Full Text] [Related]
8. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
[TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality of super-refractory status epilepticus in adults.
Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
[TBL] [Abstract][Full Text] [Related]
10. Specific characteristics and current diagnostic and treatment modalities performance of super refractory status epilepticus in children: A comparative study.
Briassoulis G; Stefanogianni C; Zaganas I; Raissaki M; Briassoulis P; Ilia S
Eur J Paediatr Neurol; 2022 Mar; 37():32-39. PubMed ID: 35051734
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
12. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
[TBL] [Abstract][Full Text] [Related]
13. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
[TBL] [Abstract][Full Text] [Related]
14. Pediatric refractory and super-refractory status epilepticus.
Vasquez A; Farias-Moeller R; Tatum W
Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
[TBL] [Abstract][Full Text] [Related]
15. Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus.
Jayalakshmi S; Patil A; Challa A; Parekh M; Khandelia H; Vooturi S
J Clin Neurosci; 2022 Mar; 97():12-16. PubMed ID: 35030458
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
[No Abstract] [Full Text] [Related]
17. Aborted and refractory status epilepticus in children: a comparative analysis.
Lambrechtsen FA; Buchhalter JR
Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
[TBL] [Abstract][Full Text] [Related]
18. A one-year prospective study of refractory status epilepticus in Modena, Italy.
Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcome of super-refractory status epilepticus: a retrospective analysis in West China.
Li Y; Tian L; Zeng T; Chen J; Chen L; Zhou D
Seizure; 2014 Oct; 23(9):722-7. PubMed ID: 24962610
[TBL] [Abstract][Full Text] [Related]
20. Stiripentol for the treatment of super-refractory status epilepticus.
Strzelczyk A; Kortland LM; Knake S; Rosenow F
Acta Neurol Scand; 2015 Dec; 132(6):435-9. PubMed ID: 25809474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
